Minitran and Haematuria - a phase IV clinical study of FDA data

Summary:

Haematuria is reported as a side effect among people who take Minitran (nitroglycerin), especially for people who are male, 60+ old, also take Lasix, and have Diabetes.

The phase IV clinical study analyzes which people have Haematuria when taking Minitran. It is created by eHealthMe based on reports of 943 people who have side effects when taking Minitran from the FDA, and is updated regularly.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

What is Haematuria?

Haematuria (presence of blood in urine) is found to be associated with 1,691 drugs and 2,528 conditions by eHealthMe. Check the latest studies of Haematuria.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

943 people reported to have side effects when taking Minitran.
Among them, 14 people (1.48%) have Haematuria.

Among these 14 people:

What is the gender of people who have Haematuria when taking Minitran? *

female: 50 %
male: 50 %

What is the age of people who have Haematuria when taking Minitran? *

What are other drugs people take besides Minitran? *

What are other side effects people have besides Haematuria? *

Bladder Cancer: 3 people, 21.43%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 21.43%
Hypertransaminasaemia: 3 people, 21.43%
Activated Partial Thromboplastin Time Prolonged: 3 people, 21.43%
Hyperbilirubinaemia (excess of bilirubin in the blood): 3 people, 21.43%
Thrombocytopenia (decrease of platelets in blood): 3 people, 21.43%
Acute Kidney Failure: 3 people, 21.43%
Depression: 2 people, 14.29%
Infection: 2 people, 14.29%
Rashes (redness): 2 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 28.57%
Diabetes: 4 people, 28.57%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 21.43%
Axillary Mass: 3 people, 21.43%
Vitamin B12 Deficiency: 2 people, 14.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 14.29%
Sleep Disorder: 2 people, 14.29%
Depression: 2 people, 14.29%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 7.14%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Minitran and have Haematuria?

- Check whether Haematuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Minitran:

Minitran (950 reports)

Haematuria treatments and more:

Haematuria (44,248 reports)

Browse all side effects of Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematuria:

Haematuria (1,691 drugs)

Browse all the conditions that are associated with Haematuria:

Haematuria (2,528 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Minitran) and Minitran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.